RYTM Rhythm Pharmaceuticals: Operatsion rentabellik

Ommaviy kompaniya Rhythm Pharmaceuticals, Inc. (RYTM) logotipi

Noyob semizlikni davolashga bo'lgan elastik bo'lmagan talab Rhythm Pharmaceuticals (RYTM) kompaniyasini iqtisodiy sikllardan mustaqil bo'lgan himoya aktiviga aylantiradi. GURU.Markets terminalidagi ushbu grafik operatsion marja profilini aks ettiradi, bunda oxirgi qiymat -66.70 deb qayd etilgan. Ushbu barqarorlik geosiyosiy xatarlarning yo'qligi hamda genetik patologiyalarni tashxislash va davolash uchun yopiq ekotizimning yaratilishi bilan yanada mustahkamlanadi, bu esa shifokorlar va bemorlar orasida barqaror sodiqlikni rag'batlantiradi.

rhythmtx.com (RYTM): Operatsion foyda normasi 04.07.2022dan 19.11.2026gacha

Rhythm Pharmaceuticals, Inc. (RYTM) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
rhythmtx.com brendining mahsuloti

Noyob semizlikni davolash bo'yicha global bozorning kengayishi Rhythm Pharmaceuticals (RYTM) kompaniyasining xarajatlarni boshqarish samaradorligiga bevosita ta'sir ko'rsatadi. Ushbu ko'rsatkich operatsion foydaning daromadga nisbati sifatida hisoblanadi va moliyaviy majburiyatlar hamda soliqlarni hisobga olishdan oldin daromad keltirish qobiliyatini aks ettiradi, bu esa operatsion marja tarixini kompaniyaning fundamental barqarorligi ko'rsatkichi sifatida baholash imkonini beradi.

Rhythm Pharmaceuticals raqobatchilari tahlili

Operatsion rentabellik Ascendis|Madrigal Corp (MDGL) - Operatsion faoliyat rentabelligi|Operatsion rentabellik corcept.com (CORT)|Sotuvning operatsion marjasi Akero Therapeutics AKRO|Operatsion rentabellik Metsera, Inc. MTSR|MLTX - Sotuvning operatsion marjasi|CRNX - Operatsion rentabellik|Sotuvning operatsion rentabelligi NewAmsterdam Pharma|Soleno Therapeutics (SLNO) - Operatsion rentabellik|FOLD - Operatsion faoliyat rentabelligi|Operatsion rentabellik 89bio Pharma|Sotuvning operatsion rentabelligi Agios AGIO|Operatsion marja GPCR|MiMedx Group, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Rezolute Bio - Sotuvning operatsion marjasi|lexpharma.com (LXRX) - Sotuvning operatsion rentabelligi|MBX - Operatsion rentabellik|ALT (Altimmune) - Operatsion foyda bo'yicha sotuv rentabelligi|Aardvark Therapeutics Inc. (AARD) - Operatsion rentabellik|Sagimet - Operatsion foyda normasi|BIOA (BioAge Labs, Inc) - Operatsion marja|Operatsion marja biomeafusion.com|Operatsion marja QNCX|GUTS - Sotuvning operatsion rentabelligi|Operatsion marja VTVT (vTv Therapeutics)|ATPC - Sotuvning operatsion marjasi|PLUR - Operatsion rentabellik|Synlogic Inc. (SYBX) - Sotuvning operatsion marjasi|LPCN (Lipocine Inc) - Sotuvning operatsion marjasi|Matinas BioPharma Holdings, Inc. - Operatsion foyda normasi|SPRB (sprucebiosciences.com) - Operatsion marja|Operatsion rentabellik GLTO|Operatsion marja CTCX|Lumos Pharma, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ONVO (organovo.com)|Operatsion foyda bo'yicha marjinallik Radius Health